Exposure–response analyses of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma

BACKGROUND: Exposure–response analyses were conducted to explore the relationship between selected efficacy and safety endpoints and serum phosphate (PO4) concentrations, a potential biomarker of efficacy and safety, in locally advanced or metastatic urothelial carcinoma patients with FGFR alteratio...

Descripción completa

Detalles Bibliográficos
Autores principales: Dosne, Anne-Gaëlle, Valade, Elodie, Goeyvaerts, Nele, De Porre, Peter, Avadhani, Anjali, O’Hagan, Anne, Li, Lilian Y., Ouellet, Daniele, Perez Ruixo, Juan Jose
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807442/
https://www.ncbi.nlm.nih.gov/pubmed/34977972
http://dx.doi.org/10.1007/s00280-021-04381-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807442/
https://www.ncbi.nlm.nih.gov/pubmed/34977972
http://dx.doi.org/10.1007/s00280-021-04381-4

Ejemplares similares